Fresenius Kabi USA, LLC

FDA Regulatory Profile

Summary

Total Recalls
84 (22 Class I)
510(k) Clearances
2
Inspections
58
Compliance Actions
2

Known Names

fresenius kabi usa, fresenius kabi, usa

Recent Recalls

NumberClassProductDate
D-0434-2026Class II0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL), 1,000 mL in a Single Dose freefMarch 11, 2026
D-0427-2026Class II0.9% Sodium Chloride Injection, USP, (2,250 mg per 250 mL) (9 mg per mL) 250 mL in a 250 mL freeflexMarch 11, 2026
D-0430-2026Class II0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 100 mL in a Single Dose freefleMarch 11, 2026
D-0433-2026Class II0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 1,000 mL in a Single Dose freefMarch 11, 2026
D-0426-2026Class II0.9% Sodium Chloride Injection, USP, 0.9% (900 mg per 100 mL) (9 mg per mL) 100 mL in a 100 mL freefMarch 11, 2026
D-0436-2026Class II5% Dextrose Injection, USP 5 g per 100 mL (50 mg per mL) 100 mL in a 100 mL freeflex bag, Fresenius March 11, 2026
D-0428-2026Class II0.9% Sodium Chloride Injection, USP, (4,500 mg per 500 mL) (9 mg per mL) 500 mL in a 500 mL freeflexMarch 11, 2026
D-0435-2026Class II5% Dextrose Injection, USP 2.5 g per 50 mL (50 mg per mL) 50 mL in a 100 mL freeflex bag, Fresenius March 11, 2026
D-0432-2026Class II0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL) 500 mL in a Single Dose freeflexMarch 11, 2026
D-0425-2026Class II0.9% Sodium Chloride Injection, USP 0.9% (450 mg per 50 mL) (9 mg per mL) 50 mL, Rx only, Fresenius March 11, 2026
D-0437-2026Class II5% Dextrose Injection, USP 12.5 g per 250 mL (50 mg per mL) 250 mL in a 250 mL freeflex bag, FreseniMarch 11, 2026
D-0431-2026Class II0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 250 mL in a Single Dose freefleMarch 11, 2026
D-0429-2026Class II0.9% Sodium Chloride Injection, USP, 50 mL x60, Becton, Dickson and Company, 1 Beckton Drive, FranklMarch 11, 2026
D-0424-2026Class II0.45% Sodium Chloride Injection, USP, 1.125 grams per 250 mL (4.5 mg per mL), 250 mL in a 250 mL freMarch 11, 2026
Z-1048-2026Class IIIvenix Infusion System (IIS), LVP Software: LVP-SW-0005.November 21, 2025
Z-0885-2026Class IIvenix Infusion System (IIS), LVP Software LVP-SW-0005. Software for the controlled administration oNovember 14, 2025
D-0182-2026Class IFamotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LNovember 6, 2025
Z-0848-2026Class IIIvenix Infusion System (IIS), Large Volume Pump. Model Number: LVP-0004.November 3, 2025
Z-0586-2026Class IIVENIX INFUSION SYSTEM, LVP Primary Administration Set, Dual-Inlet, Low-Sorbing, Needle-Free Port, DNovember 3, 2025
Z-0378-2026Class IIIvenix Infusion System (IIS), Large Volume Pump. Model Number: LVP-0004.September 3, 2025

Recent 510(k) Clearances

K-NumberDeviceDate
K180615AMICUS Separator System, AMICUS Exchange Kit - Therapeutics, Waste Transfer Set, Blood Component FilDecember 4, 2018
K162462AMICUS Separator System, AMICUS Separator System; RefurbishedNovember 23, 2016